Repurposing of FDA-approved drugs as potential inhibitors of the SARS-CoV-2 main protease: Molecular insights into improved therapeutic discovery

por Ray, Abhik Kumar, Sen Gupta, Parth Sarthi, Panda, Saroj Kumar, Biswal, Satyaranjan, Bhattacharya, Uddipan, Rana, Malay Kumar
Publicado 2022